Health Benefits: Medicare’s Costly Doughnut Hole
Seniors dread this regulate of year, when they run out of Medicare drug coverage and have to pay out of pocket. Some just stop taking their drugs
by Arlene Weintraub
For many persons older Americans, this is a bitter time of year through a deceptively sweet name: the "doughnut hole."
It’s not a treat from the local bakery, but more readily a coverage gap in the three-year-old Medicare Part D drug program. When Part D was first designed as a way to help somewhat old patients pay for their prescription drugs, the only way the federal conduct could spare it was to prescribe a yearly limit on which it would cover for each member. So one interval seniors consume drugs up to that opening—it is $2,510 in 2008—they fall into the doughnut hollow. They then require to pay fully out of pocket for their drugs to the time when the end of the year, or until they’re legally qualified beneficial to catastrophic coverage, whichever comes first.
The doughnut opening has been a source of angst ever since Part D began in 2004. Now we know why: One way seniors deal with being in the hole is to stop taking their drugs.
More than 3 Million AffectedOnly recently have pollsters been able to quantify the fallout of the doughnut cave. In August, the Henry J. Kaiser Family Foundation released results of a survey showing that in 2007, 26% of Part D beneficiaries—3.4 million people—reached the doughnut hole. Part D plans are offered and managed by private security against loss companies, likewise the particulars differ among the 1,600 or such plans that are suitable. But on average, Part D patients who fell into the doughnut hole saw their monthly out-of-pocket costs hollow to $196.
Even more alarming was that the study found 15% of people through chronic illnesses stopped taking drugs during the time they were in the coverage gap. "High drug costs are a barrier, but this is the first time we’re seeing it documented so plainly," says Tricia Neuman, vice-president at Kaiser Family Foundation, a Menlo Park (Calif.) health research construction. "This raises concerns about the consequences for people with serious chronic conditions."
So what is the purpose of the doughnut hole exactly? It was the only solution to a simple problem: The federal government, which is expected to squander betwixt $395 billion and $534 billion on Part D benefits through 2013, didn’t allocate a swelling enough lot to the program to subsidize an unlimited supply of drugs for each beneficiary. Some of the insurance companies that sell Part D plans offer options that cover drugs for the period of the gap. But, says David Certner, legislative prudence director toward AARP, "those plans cost more and they only cover generic drugs."
Reconsidering RetirementSince seniors already have to pay premiums and co-pays on their Part D plans, many choose to venture falling into the hole the more in this way than to pay more with respect to the chance of staying out of it.
Larry Kay of Yukaipa, Calif., is having so much trouble affording the doughnut hole that he’session thinking about coming out of retirement. Kay, a former quality-control inspector for a fencing company, hit the hole in May and is now profitable $650 a month for drugs to delight his ostentatious cholesterol and the lung predicament chronic obstructive pulmonary sickness, or COPD. "One is $162, not the same is $226," he says, rattling the exact prices distant from the top of his head with the tone of both familiarity and annoyance. "They don’t have generics."
Kay’s pension of $1,198 per month (after taxes) leaves little left over notwithstanding other essentials. So he has stopped taking his COPD inhaler in the morning, even though he’s not supposed to skip doses. "If my doctor knew, he’d be very upset."
Filling the Hole: Different IdeasHealth policy experts believe that the next Administration will exist under pressure to invocation the doughnut cave, and both candidates possess expressed some support for reforming the program. Senator Barack Obama (D-Ill.) endorses the idea of letting the commonwealth sell drug prices for Part D (it doesn’t have the right to execute so now). Senator John McCain (R-Ariz.) has said that higher-income beneficiaries should pay higher premiums for their Part D plans.
